Posttraumatic stress disorder (PTSD) is characterized by intrusive, avoidance, and hyperarousal symptoms. This study was conducted to investigate the effectiveness of divalproex in reducing PTSD symptoms, depression, and anxiety in patients with PTSD. Sixteen patients with a DSM-IV diagnosis of PTSD at the Albuquerque VAMC outpatient PTSD treatment program received an open-label trial of divalproex. The patients were evaluated at baseline and at 8 weeks by a trained rater using the Clinician Administered PTSD Scale (CAPS), the Hamilton Rating Scale for Depression (HAM-D) and the Hamilton Rating Scale for Anxiety (HAM-A). Plasma valproate levels were measured at the 8-week post-treatment assessment. Three patients stopped the medications due to side effects. Intrusion and hyperarousal symptoms decreased significantly, while no significant change was seen in avoidance/numbing symptoms. Depressive symptoms, as measured by the HAM-D, unexpectedly decreased at post-treatment assessment. HAM-A scores also decreased significantly. Controlled trials are needed to further study the efficacy of divalproex in the treatment of PTSD.

X-ray single-crystal study, molecular mechanics calculations, and calculations of the static nonlinear polarizabilities (β and γ) were performed for dicyanovinylbenzene and series of its mono- and dimethoxy-substituted derivatives. X-ray analysis has been done for dicyanovinylbenzene, its o- and p-methoxy- and 2,4-dimethoxy-substituted derivatives together with corresponding EFISH measurements of the β values for these compounds. Nonlinear polarizabilities were calculated for all series of the mono- and disubstituted methoxy derivatives of the parent compound with modified finite-field formalism that included calculation of polarization values versus static electric fields using semiempirical Hamiltonian, polynomial fit of all tensor elements of β and γ on the former data, and evaluation of the numerical instability of the calculations. All calculations were performed with optimized molecular geometries taken from X-ray data, molecular mechanics, ab initio, and semiempirical quantum chemical results. Good correlation was found between the predicted static and experimental molecular values of β. A factor of 2.0 was found to be a probable adjustment parameter to account for the solvent (1,4-dioxane) and dispersion (at 1064 nm) effects. Crystal packing analysis of the X-ray structures studied together with energetic calculations revealed the factors responsible for formation of centrosymmetric crystals. Only o-methoxydicyanovinylbenzene (also known as DIVA) forms acentric crystals (space group P21) among the experimentally studied compounds, and it was found that its molecular dipole moment orientation with respect to the polar crystal axis is close to the “optimal” for a manifestation of the high NLO responses.

No abstract

No abstract

No abstract

No abstract

X-ray single-crystal structures, molecular mechanics (MM) calculations of the optimal molecular dimers, and calculations of the static second-order polarizabilities (β) were performed for a large series of methoxyand dimethylamino-substituted derivatives of dicyanovinylbenzene and some of its analogues having large values of the molecular nonlinear optical susceptibilities. X-ray structural analysis has been performed for 3,4-dimethoxy-and 3,4,5-trimethoxy-dicyanovinylbenzenes (I,Crystal packing analysis and energetic MM calculations revealed the factors responsible for the formation of the centrosymmetric crystals. Compounds III and V were found to form acentric crystal structures (space groups P2 1 and Pc, respectively) and therefore are capable to the second-harmonic generation (SHG) in solid state. Qualitative data have demonstrated that compound V is rather active in SHG in the powder state (using Nd:YAG laser with λ ) 1064 nm) that may be important for its application. On the contrary, the powder of III is not active in SHG despite the "optimal" crystal packing that might be related to the strong absorption of the second harmonic light at λ ) 532 nm, but this compound gives strong SHG signal using the laser light with λ ) 1907 nm. Analysis of the influence of the different substituents in the aromatic ring on the calculated β values in the series of the compounds studied was made.

This study was designed to investigate the efficacy of the antidepressant drug bupropion in the treatment of posttraumatic stress disorder (PTSD). Seventeen male combat veterans with chronic PTSD were treated with bupropion in an open-label fashion for 6 weeks. Patients were evaluated with the Clinical Global Impressions Scale for Improvement (CGI-I) at follow-up and rated blindly at baseline and posttreatment with the Clinician Administered PTSD Scale (CAPS), the Hamilton Rating Scale for Depression (HAM-D), and the Hamilton Rating Scale for Anxiety. Three patients discontinued bupropion prematurely because of side effects. Of the remaining 14 patients, 10 were classified as treatment responders by the CGI-I. HAM-D scores decreased significantly from baseline to follow-up. The improvement seen in hyperarousal symptoms was significant but was less significant than the change in depressive symptoms. There was no significant change in Intrusion, Avoidance, or total CAPS scores. It was concluded that bupropion was well tolerated. Patients who had experienced sexual dysfunction with selective serotonin reuptake inhibitors reported no complaints during bupropion treatment. Bupropion decreased depressive symptoms and most patients reported global improvement, although PTSD symptoms remained mostly unchanged. Controlled trials should further clarify the role of bupropion in the treatment of PTSD.